Upstate Active Clinical Trials
Study Title:RTOG 1008 - A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
What is the purpose of the study?This randomized phase II trial is studying radiation therapy with or without chemotherapy to see how well it works in treating patients with high-risk malignant salivary gland tumors that have been removed by surgery.
Upstate Institutional Review Board (IRB) Number:242054
Patient Age Group:Adults
Principal Investigator:Seung Shin Hahn, MD
Who can I contact for more information?
Name: Dena R Martin